Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesModeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden
International Journal of Technology Assessment in Health Care, 04/17/09
Lindgren P et al. - A strategy where rituximab is used as second line treatment after failure of the first TNF inhibitor provides a small saving (essentially due to the lower price of rituximab) and a QALY gain (due to better effect than the mix of second line TNF inhibitors).
Related Articles
Treatment of adult inflammatory myositis with rituximab: An emerging therapy for refractory patients
Journal of Clinical Rheumatology (JCR), 10/08/09
Relevance Score: 90%
Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection
Nephrology, 10/07/09
Relevance Score: 89%
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: Effects of rituximab
Annals of Oncology, 11/10/09
Relevance Score: 88%
Prevention of hepatitis B virus reactivation under rituximab therapy
Immunotherapy, 11/06/09
Relevance Score: 88%
A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma
British Journal of Cancer, 11/20/09
Relevance Score: 87%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
A Clinical Review of Echinocandins in Pediatric Patients
Annals of Pharmacotherapy, 12/16/09
Use of psychotropic drugs and analgesics among users of antiobesity drugs - a population based study
Pharmacoepidemiology and Drug Safety, 12/16/09
Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia
Health Policy, 12/16/09
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor